Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Universe Pharmaceuticals INC (UPC)

5.09
+0.62
+(13.87%)
At close: May 7 at 4:00:01 PM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Gang Lai CEO & Chairman -- -- 1968
Ms. Lin Yang CFO & Director -- -- 1976
Mr. Baochang Liu Chief Operating Officer -- -- 1980

Universe Pharmaceuticals INC

265, Jingjiu Avenue
Jinggangshan Eco & Tech Dev Zn
Ji'An, 343100
China
86 79 6840 3309 https://www.universe-pharmacy.com
Sector: 
Healthcare

Description

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Corporate Governance

Universe Pharmaceuticals INC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

April 29, 2025 at 12:00 AM UTC

20-F: Periodic Financial Reports

March 20, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

March 11, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

February 25, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

February 20, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

February 11, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

February 3, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

January 27, 2025 at 12:00 AM UTC

NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F

December 12, 2024 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

November 13, 2024 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

Related Tickers